Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MIE | Ann:Prelimiary Report 2025 | 03/07/25 | 0 | 208 | |||
|
|||||||
MIE | Ann:Continuous Suspension from Official Quotation | 01/07/25 | 0 | 183 | |||
|
|||||||
MIE | Ann:Continuous Suspension from Official Quotation | 18/06/25 | 0 | 249 | |||
|
|||||||
MIE | Ann:Update on Preliminary Financial Report Submission | 13/06/25 | 0 | 273 | |||
|
|||||||
MIE | Ann:MIE PAY Announces Strategic Realignment (Price Sensitive) | 07/01/25 | 0 | 437 | |||
|
|||||||
MIE | Ann:Continued Suspension from Official Quotation (Price Sensitive) | 16/12/24 | 0 | 479 | |||
|
|||||||
MIE | Ann:Continued Suspension from Official Quotation - Failure to lodge Preliminary Final Report for 31... | 01/07/24 | 0 | 517 | |||
|
|||||||
MIE | Ann:Continued Suspension from Official Quotation - Failure to lodge Preliminary Final Report for 31... | 17/06/24 | 0 | 507 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||